Mode
Text Size
Log in / Sign up

Severe COVID-19 ARDS

Part of SARS-CoV-2 infection

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across SARS-CoV-2 infection

Related studies from across the SARS-CoV-2 infection family.

Patients with post-COVID syndrome face significant thromboembolic risk requiring proactive monitoring and tailored anticoagulant treatments
Cardiology Meta-analysis
Patients with post-COVID syndrome face significant thromboembolic risk requiring proactive monitoring and tailored anticoagulant treatments Anticoagulant Drugs May Help Manage Thromboembolic Risks After COVID-19
This meta-analysis examines the prevalence of thromboembolic events in individuals with post-COVID syndrome. The analysis identifies a signi…
People with post-COVID syndrome may face a higher risk of blood clots, highlighting the need for proactive monitoring and tailored treatment…
E3 ubiquitin ligases modulate SARS-CoV-2 replication and immune evasion through targeted protein degradation mechanisms
Allergy & Immunology Sys. Review
E3 ubiquitin ligases modulate SARS-CoV-2 replication and immune evasion through targeted protein degradation mechanisms SARS-CoV-2 uses host enzymes to hide from the immune system
This mini-review explores the role of E3 ubiquitin ligases in the context of SARS-CoV-2 infection. The authors synthesize how these enzymes …
New research shows how the virus hijacks specific proteins in our cells to replicate and dodge our body's natural defenses.
Casirivimab plus imdevimab reduced risk of hospitalization or death in patients with and without asthma
Allergy & Immunology RCT
Casirivimab plus imdevimab reduced risk of hospitalization or death in patients with and without asthma Trial shows antibody treatment helps COVID-19 patients with asthma
This randomized controlled trial evaluated casirivimab plus imdevimab (CAS + IMD) in outpatients with acute COVID-19. The study found that C…
A new trial shows a dual antibody treatment reduces hospitalization and death risk for COVID-19 patients, including those with asthma or ato…
Erratum issued for telehealth trends study during early COVID-19 pandemic
Infectious Disease
Erratum issued for telehealth trends study during early COVID-19 pandemic Erratum notice issued for a report on telehealth trends during COVID-19
An erratum notice has been published for a report on telehealth use trends during the emergence of the COVID-19 pandemic. The original study…
A correction notice clarifies that no new telehealth data exists for the early COVID-19 pandemic, so readers should consult the original rep…
Erratum issued for COVID-19 hospitalization data among health care personnel
Infectious Disease
Erratum issued for COVID-19 hospitalization data among health care personnel What happened to health care workers hospitalized with COVID-19? A correction notice.
An erratum notice was published regarding data on COVID-19-associated hospitalizations among health care personnel from the COVID-NET survei…
A correction notice clarifies that a previous report on health care workers hospitalized with COVID-19 did not contain new data or findings.
Long COVID cardiovascular care should shift to mechanism-informed, subgroup-based management
Cardiology Sys. Review
Long COVID cardiovascular care should shift to mechanism-informed, subgroup-based management Current Long COVID care relies on symptom management while future research targets specific mechanisms
This mini review synthesizes current evidence on cardiovascular Long COVID. It argues that management remains symptom-based and calls for st…
Current Long COVID care relies on symptom management while future research targets specific mechanisms for better outcomes.
Interleukin-7 therapy improves lymphocyte counts in sepsis and COVID-19 patients
Emergency Medicine Meta-analysis
Interleukin-7 therapy improves lymphocyte counts in sepsis and COVID-19 patients Recombinant human interleukin-7 boosts white blood cells but does not save lives in sepsis or COVID-19
A meta-analysis shows recombinant IL-7 boosts lymphocytes in sepsis and COVID-19, but only reduces secondary infections in COVID-19.
A new analysis shows this drug raises low white blood cell counts in sepsis and COVID-19 but does not lower death risk or improve survival.
Review of RISE-mitigation strategies in Ghana shows high immunization coverage and improved oxygen access
Radiology & Imaging Sys. Review
Review of RISE-mitigation strategies in Ghana shows high immunization coverage and improved oxygen access Ghana reduced oxygen travel distances and improved vaccine coverage with new pandemic strategies
This review uses mixed qualitative and quantitative approaches to evaluate RISE-mitigation strategies in Ghana. The analysis covers 10 novel…
New strategies in Ghana helped get oxygen closer to patients and reached 93% of people with vaccines while treating most confirmed cases.
Narrative review on COVID-19 and gut microbiome disruption and immune effects
Infectious Disease Sys. Review
Narrative review on COVID-19 and gut microbiome disruption and immune effects Microbiome disruption may link SARS-CoV-2 to long-term health issues
This narrative review synthesizes evidence on COVID-19 and the intestinal microbiome. It finds SARS-CoV-2 infection can induce dysbiosis and…
A review suggests the virus may alter gut bacteria, immune signals, and brain health, highlighting a need for One Health pandemic preparedne…
Speleotherapy improves asthma control and breathing patterns in patients with respiratory conditions
Allergy & Immunology RCT
Speleotherapy improves asthma control and breathing patterns in patients with respiratory conditions Speleotherapy improves breathing patterns and symptoms for asthma, COPD, and Long COVID patients
A randomized trial of 208 patients across Germany, Austria, and Italy found that a three-week speleotherapy course enhanced asthma control a…
A three-week course in mineral-rich caves helped people with asthma, COPD, or Long COVID breathe easier and feel better, though lung functio…
Systematic review and meta-analysis links COVID-19 infection to 41% higher new-onset diabetes risk
Diabetes & Endocrinology Meta-analysis
Systematic review and meta-analysis links COVID-19 infection to 41% higher new-onset diabetes risk Meta-analysis links COVID-19 infection to higher new-onset diabetes risk
This systematic review and meta-analysis evaluated sixteen studies comparing COVID-19 survivors with non-infected individuals. The pooled an…
A meta-analysis of sixteen studies suggests COVID-19 infection is associated with a 41% increased risk of developing new-onset diabetes at l…
Systematic review finds convalescent plasma does not reduce mortality in COVID-19
Allergy & Immunology Sys. Review
Systematic review finds convalescent plasma does not reduce mortality in COVID-19 Convalescent plasma does not reduce COVID-19 death risk
This systematic review of 48 RCTs (24,518 participants) found that convalescent plasma does not reduce all-cause mortality or improve clinic…
A large review of 48 trials finds convalescent plasma doesn't lower death risk in moderate to severe COVID-19. For mild cases, evidence is u…